International Research Foundation for RSD / CRPS

 

Welcome to the International Research Foundation for RSD / CRPS Web site.

For more information about Reflex Sympathetic Dystrophy (RSD),

please visit the sections below:

 

The RSD / CRPS Treatment Center & Research Institute Launches New Website

 

Incompetent IRBs and FDA prevent research on RSD / CRPS

Outpatient Ketamine: Two Well-Controlled Studies

 

RSD Can Also Decrease Perception To Pain

 

People Magazine Reports on Ketamine Coma Study

 

Canadian Government Approves Ketamine Infusion at The RSD / CRPS Treatment Center & Research Institute

 

Foundation Launches CME Program

 

3-Day / 4-Hour Outpatient Treatment with High Dose Ketamine

 

Ketamine Coma Study Published

Treatment Center Opens

 

American Medical Association Is Injuring Patients with RSD

 

 

Videos

Use of Opioids (Narcotics) to treat RSD / CRPS in Children &Adults
(Video)

(Transcript)

(Transcript)

Highlights: Emotional consequences of RSD
(Video)(Transcript)

How You Can Help
(Video)

 

RSD / CRPS News

Use of Ketamine to Treat Depression

Fraud Case Rocks Anesthesiology Community

Ketamine Coma Study: Risk / Benefit Analysis ~ 3-Minute Video

Panel Discussion on the Ketamine Coma Study

ANESTHESIOLOGY NEWS: Relief for Worst RSD May Lie With Ketamine Coma

Live Broadcast: Ketamine Coma Study

FOX NEWS: "The Coma Cure"

CNN Reports On RSD / CRPS

The Cutting Edge of Pain Treatment

The American Academy of Neurology Reports on Ketamine Research

Subcutaneous Peripheral Nerve Stimulation

Advances in Neurostimulation Systems

Video Presentation of Sympathetic Nerve Blocks

High Dose Ketamine Research Video Presentation -- With Patient Update

Intranasal Ketamine Development

Update: Clinical Trial at NIH on Neurotropin

Well-Controlled Clinical Trial on Lenalidomide

Functional MRI Research Study in Children & Adoloescents

 

Foundation News

 

Pregnancy & CRPS

Medical Synopsis of Volunteers for the Ketamine Coma Study

FOX Television: Selecting a Pain Clinic

FOX Television: Counting on a Coma

PART I: FDA Policy Results in Exporting Pain Studies Overseas

PART II: Foundation Appeals FDA Decision as Improper and Retaliatory

FOX Television: Reflex Sympathetic Dystrophy

Mexico IRB Approves Ketamine Coma Study

Two-Hour Ketamine Infusion Treatment [Video Demonstration]

Dr. Cantu Receives Award

Foundation's Accomplishments 2006

New Foundation Vice President

Debut of Italian Website with Video Presentation

New Ranking for the Foundation's Website by Google

Announcing New Chinese Website with Video Presentation

Foundation Scientists Interviewed on High Dose Ketamine -- VIDEO

Foundation Meets the Needs of the Top 7 Languages

Foundation Ranked # 1

Foundation's Guidelines Published by US Government Agency

ABC News Interviews Dr. Schwartzman on High Dose ketamine Research

Scientific Advisory Committee Assists US Government

Foundation Praised By Pain Experts

Dr. Covington Joins Scientific Advisory Committee

Dr. Raja Publishes Review on RSD / CRPS

LIVE, INTERACTIVE Internet Broadcast on RSD / CRPS

 

Profiles

Dr. Gustavo Roman and Dr. Berde Dr. Anthony Kirkpatrick h

Dr. Roman and Dr. Kirkpatrick

 

Important Foundation Information


How to Determine the Effectiveness of Treatments for RSD / CRPS

Clinical Practice Guidelines For RSD / CRPS -   Third Edition

Research Updates on RSD / CRPS

Board of Directors

Officers of the Foundation

Scientific Advisory Committee

Mission Statement

Honorary Donors

Patient Resources - New

Contact Us

 

Because everyone is different, the information expressed herein cannot and should not be used to diagnose or treat individual health problems. A health care professional can best guide you.

 


HOME  |  MENU  |   DONATE  |   CONTACT US

The International Research Foundation for RSD / CRPS is a
501(c)(3) (not-for-profit) organization in the United States of America.


Copyright © 2003 International Research Foundation for RSD / CRPS.
All rights reserved.
For permission to reprint any information on the website, please contact the Foundation.